PFBT
AMRI

Parkside Financial Bank & Trust’s Albany Molecular Research Inc AMRI Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-21
Closed – – 1635
2017
Q2 		$0 Buy
+21
New +$381 ﹤0.01% 1651

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Parkside Financial Bank & Trust's AMRI Position: Q3 2017 in Review

Parkside Financial Bank & Trust sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 21 shares.

Parkside Financial Bank & Trust first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $0 in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Parkside Financial Bank & Trust reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 21 Albany Molecular Research Inc shares in Q3 2017.
  • Parkside Financial Bank & Trust first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Albany Molecular Research Inc position peaked at $0 in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2017, filed 27 Oct 2017.